Abstract
Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolded proteins, in this latter function cooperating with the ubiquitin-proteasome system (UP system). Although autophagy has been known for a long time, its involvement in the pathogenesis of neurodegenerative diseases has been investigated only recently. The most fascinating data are very recent and show an impressive connection between proteins that are mutated in different forms of familial Parkinsons Disease (PD) and the critical role that these proteins play in the physiology of the Autophagy (ATG) pathway. This evidence is supported by neuropathological data showing at the ultrastructural level, the occurrence of an altered ATG in the dopamine (DA) neurons of the Substantia Nigra of patients affected by PD. Accordingly, by using experimental models of PD the involvement of ATG is documented as well. In particular, administration of the DA neurotoxin methamphetamine produces damage to DA-containing cells which is exacerbated and results in neuronal cell death when the ATG pathway is inhibited, thus confirming ATG as a critical pathway for the survival of DA neurons. In the present manuscript, after describing the general molecular and cellular features of ATG, we give a short overview of the most relevant aspects concerning the involvement of ATG in the pathogenesis of PD. We further propose that the ATG and the UP systems might converge in the formation of a so-called “autophagoproteasome” which might represent an early ultrastructure witnessing the presence of an ongoing degeneration within DA cells.
Keywords: Parkinson's Disease, ATG, alpha-synuclein, dopamine, proteasome, autophagoproteasome, methamphetamine, lysosome
Current Topics in Medicinal Chemistry
Title: The Role of Autophagy on the Survival of Dopamine Neurons
Volume: 9 Issue: 10
Author(s): Ciro Isidoro, Francesca Biagioni, Filippo Sean Giorgi, Federica Fulceri, Antonio Paparelli and Francesco Fornai
Affiliation:
Keywords: Parkinson's Disease, ATG, alpha-synuclein, dopamine, proteasome, autophagoproteasome, methamphetamine, lysosome
Abstract: Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolded proteins, in this latter function cooperating with the ubiquitin-proteasome system (UP system). Although autophagy has been known for a long time, its involvement in the pathogenesis of neurodegenerative diseases has been investigated only recently. The most fascinating data are very recent and show an impressive connection between proteins that are mutated in different forms of familial Parkinsons Disease (PD) and the critical role that these proteins play in the physiology of the Autophagy (ATG) pathway. This evidence is supported by neuropathological data showing at the ultrastructural level, the occurrence of an altered ATG in the dopamine (DA) neurons of the Substantia Nigra of patients affected by PD. Accordingly, by using experimental models of PD the involvement of ATG is documented as well. In particular, administration of the DA neurotoxin methamphetamine produces damage to DA-containing cells which is exacerbated and results in neuronal cell death when the ATG pathway is inhibited, thus confirming ATG as a critical pathway for the survival of DA neurons. In the present manuscript, after describing the general molecular and cellular features of ATG, we give a short overview of the most relevant aspects concerning the involvement of ATG in the pathogenesis of PD. We further propose that the ATG and the UP systems might converge in the formation of a so-called “autophagoproteasome” which might represent an early ultrastructure witnessing the presence of an ongoing degeneration within DA cells.
Export Options
About this article
Cite this article as:
Isidoro Ciro, Biagioni Francesca, Giorgi Sean Filippo, Fulceri Federica, Paparelli Antonio and Fornai Francesco, The Role of Autophagy on the Survival of Dopamine Neurons, Current Topics in Medicinal Chemistry 2009; 9 (10) . https://dx.doi.org/10.2174/156802609789378281
DOI https://dx.doi.org/10.2174/156802609789378281 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Beta-Blockers Action in Patients with Heart Failure
Reviews on Recent Clinical Trials Fibrosis, Enzymatic and Non-Enzymatic Cross-Links in Hypertensive Heart Disease
Cardiovascular & Hematological Disorders-Drug Targets Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Vasorelaxant and Antihypertensive Effects of <i>Mentha pulegium</i> L. in Rats: An In vitro and In vivo Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction
Current Pharmaceutical Design Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases
Current Pharmaceutical Design Cyclodextrins as Food Additives and in Food Processing
Current Nutrition & Food Science From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors
Current Medicinal Chemistry Genetics of Atherosclerosis in Murine Models
Current Drug Targets Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
Current Pharmaceutical Biotechnology microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets A Yeast Extract High in Bioactive Peptides has a Blood-Pressure Lowering Effect in Hypertensive Model
Current Medicinal Chemistry Evaluating 3D-printed Bolus Compared to Conventional Bolus Types Used in External Beam Radiation Therapy
Current Medical Imaging Lymphatic Delivery of Anti-HIV Drug Nanoparticles
Recent Patents on Nanotechnology Inhibition of Platelet Adhesion to Collagen as a New Target for Antithrombotic Drugs
Current Drug Targets - Cardiovascular & Hematological Disorders Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide
Drug Metabolism Letters Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Episcleritis and Scleritis in Rheumatic Disease
Current Rheumatology Reviews